Australian Cannabis Supplier Elixinol Reports Strong Q3 Growth Australian medicinal cannabis supplier Elixinol Global (ASX: EXL) has reported revenue growth of 159% as Q3 sales hit AU$10.4 million ($7.4 million). Its Q3 ... Read More»